Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications

Hitting the evasive tumor cells proves challenging in targeted cancer therapies. A general and unconventional anticancer approach namely small molecule sequential dual-targeting theragnostic strategy (SMSDTTS) has recently been introduced with the aims to target and debulk the tumor mass, wipe out t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junjie, Oyen, Raymond, Verbruggen, Alfons, Ni, Yicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572405/
https://www.ncbi.nlm.nih.gov/pubmed/23412554
http://dx.doi.org/10.7150/jca.5635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572405/
https://www.ncbi.nlm.nih.gov/pubmed/23412554
http://dx.doi.org/10.7150/jca.5635

Ejemplares similares